/logo.svgIpoTec


Amwill Health Care Ipo


Objects of the Issue

  • To be finalized on determination of the Offer Price and updated in the Prospectus prior to filing with the ROC

  • The amount to be utilised for general corporate purposes shall not exceed 25% of the Gross Proceeds of the Offer

Amwill Health Care IPO Review

  • IPO Watch – May Apply

  • Canara Bank –

  • DRChoksey FinServ –

  • Emkay Global –

  • Hem Securities –

  • IDBI Capital –

  • Marwadi Shares –

  • Nirmal Bang –

  • SBICAP Securities –

  • Sharekhan –

  • SMC Global –

  • Sushil Finance –

  • Swastika Investmart –

  • Ventura Securities –

  • Geojit –

  • Reliance Securities –

  • Capital Market –

  • BP Wealth –

  • ICICIdirect –

  • Choice Broking –

IPO Lead Managers aka Merchant Bankers

  • Unistone Capital Private Limited

  • Bigshare Services Private Limited

ApplicationLot SizeSharesAmount
Retail Minimum11200₹1,33,200
Retail Maximum11200₹1,33,200
S-HNI Minimum22,400₹2,66,400

IPO Open Date:February 5, 2025
IPO Close Date:February 7, 2025
Basis of Allotment:February 10, 2025
Refunds:February 11, 2025
Credit to Demat Account:February 11, 2025
IPO Listing Date:February 12, 2025

Period EndedRevenueExpenseProfit After TaxAssets
2022₹27.62₹24.28₹2.57₹6.59
2023₹30.28₹26.11₹3.11₹12.39
2024₹44.28₹27.52₹12.54₹18.98
September 2024₹23.25₹14.50₹6.52₹28.89

KPIValues
ROE:73.06%
ROCE:94.16%
EBITDA Margin:37.92%
PAT Margin:28.53%
Debt to equity ratio:NA
Earning Per Share (EPS):₹8.04 (Basic)
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):73.06%
Net Asset Value (NAV):₹11.00

CompanyEPSPE RatioRoNW %NAVIncome
Vaishali Pharma Limited0.6826.451.68%39.9786.28 Cr.
Trident Lifeline Limited6.1345.0613.37%45.8144.65 Cr.

IPO Open Date:February 5, 2025
IPO Close Date:February 7, 2025
Face Value:₹10 Per Equity Share
IPO Price Band:₹105 to ₹111 Per Share
Issue Size:Approx ₹59.98 Crores
Fresh Issue:Approx ₹11.1 Crores
Offer for Sale:Approx 10,00,000 Equity Shares
Issue Type:Book Built Issue
IPO Listing:BSE SME
Retail Quota:Not more than 40%
QIB Quota:Not more than 20%
NII Quota:Not more than 40%
DRHP Draft Prospectus:Click Here
RHP Draft Prospectus:Click Here
Anchor Investors List:Click Here

Disclaimer:Logos and other registered trademarks of funds used on this platform are held by their respective owners. IpoTec does not claim ownership or association on them, and their use is purely for informational and illustrative purposes.

Copyrights ©2025 IpoTec. All rights reserved.